Meadow Creek Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.38M Sell
1,497
-2,218
-60% -$2.25M 0.89% 24
2025
Q4
$3.99M Buy
3,715
+51
+1% +$48.8K 2.55% 9
2025
Q3
$3M Sell
3,664
-296
-7% -$220K 1.99% 10
2025
Q2
$3.09M Buy
3,960
+2,237
+130% +$1.74M 2.08% 10
2025
Q1
$1.42M Sell
1,723
-143
-8% -$119K 1.06% 19
2024
Q4
$1.44M Sell
1,866
-181
-9% -$150K 1.04% 22
2024
Q3
$1.81M Buy
2,047
+126
+7% +$113K 1.44% 15
2024
Q2
$1.74M Sell
1,921
-2,240
-54% -$1.79M 1.64% 14
2024
Q1
$3.24M Buy
4,161
+2,202
+112% +$1.57M 2.25% 8
2023
Q4
$1.14M Buy
+1,959
New +$1.14M 1.11% 19
2022
Q3
$570K Sell
1,763
-1
-0.1% -$317 0.75% 29
2022
Q2
$572K Sell
1,764
-24
-1% -$7.2K 0.7% 26
2022
Q1
$512K Hold
1,788
0.56% 45
2021
Q4
$494K Buy
+1,788
New +$453K 0.47% 52
2019
Q4
$232K Buy
+1,763
New +$204K 0.32% 83

Other funds holding LLY

Meadow Creek Wealth Advisors's LLY Position: Q1 2026 in Review

Meadow Creek Wealth Advisors reduced its Eli Lilly (LLY) stake by 60% in Q1 2026, selling an estimated $2.25M and leaving 1,497 shares worth $1.38M. The position accounts for 0.89% of the portfolio, ranked #24.

Meadow Creek Wealth Advisors first reported a position in LLY in Q4 2019 and has held it in 15 quarters since. The position peaked at $3.99M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Meadow Creek Wealth Advisors held 1,497 shares of Eli Lilly worth $1.38M as of Q1 2026.
  • Meadow Creek Wealth Advisors sold 2,218 Eli Lilly shares in Q1 2026, an estimated $2.25M.
  • Eli Lilly made up 0.89% of Meadow Creek Wealth Advisors's portfolio in Q1 2026, its #24 holding.
  • Meadow Creek Wealth Advisors first reported a position in Eli Lilly in Q4 2019 and has held it in 15 quarters since.
  • Meadow Creek Wealth Advisors's Eli Lilly position peaked at $3.99M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Meadow Creek Wealth Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.